{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T09:35:18Z","timestamp":1793957718220,"version":"4.8.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T00:00:00Z","timestamp":1704499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T00:00:00Z","timestamp":1704499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the National Key Technology Research and Developmental Program of China","award":["2022YFC2704404"],"award-info":[{"award-number":["2022YFC2704404"]}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["2021-I2M-5-001"],"award-info":[{"award-number":["2021-I2M-5-001"]}]},{"DOI":"10.13039\/501100007129","name":"Shandong Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["ZR2022JQ33"],"award-info":[{"award-number":["ZR2022JQ33"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Special Support Program for High-level Talents"},{"name":"Taishan Scholars Program for Young Experts of Shandong Province","award":["tsqn201909195"],"award-info":[{"award-number":["tsqn201909195"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Polycystic ovarian syndrome (PCOS) is recognized as the most prevalent endocrine disorder among women of reproductive age. While the utilization of assisted reproductive technology (ART) has resulted in favorable outcomes for infertility treatment in PCOS patients, the inherent pathophysiological features of the condition give rise to complications and consequences during pregnancy and delivery for both the mother and offspring. This study was to assess the correlation between maternal PCOS and various pregnancy complications and neonatal outcomes undergone ART.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A systematic search was conducted on PubMed, EmBase, and the Cochrane Library to identify observational studies that investigated the association between PCOS and the risk of various pregnancy complications and neonatal outcomes, including gestational diabetes mellitus (GDM), hypertension in pregnancy (PIH), preeclampsia (PE), preterm birth, abortion, congenital malformations (CA), small for gestational age (SGA), large for gestational age (LGA), low birth weight (LBW), macrosomia, neonatal intensive care unit (NICU) admission and birth weight. Eligible studies were selected based on predetermined inclusion and exclusion criteria. The meta-analysis was conducted using Review Manager and Stata software, with odds ratios (ORs) or mean difference (MD), confidence intervals (CIs), and heterogeneity (I<jats:sup>2<\/jats:sup>) being calculated. The search was conducted up to March 2023.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 33 studies with a combined sample size of 92,810 participants were identified. The findings indicate that PCOS is significantly associated with an increased risk of GDM (OR 1.51, 95% CI:1.17\u20131.94), PIH (OR 1.72, 95% CI:1.25\u20132.39), PE (OR 2.12, 95% CI:1.49\u20133.02), preterm birth (OR 1.29, 95% CI:1.21\u20131.39), and LBW (OR 1.29, 95% CI:1.14\u20131.47). In subgroup analyses, the risks of GDM (OR 1.80, 95% CI:1.23\u20132.62) and abortion (OR 1.41, 95% CI:1.08\u20131.84) were elevated in fresh embryo transferred (ET) subgroup, whereas elevated risk of PE (OR 1.82, 95% CI:1.17\u20132.83) and preterm birth (OR 1.31, 95% CI:1.21\u20131.42) was identified in frozen ET subgroup. Whatever with or without hyperandrogenism, patients with PCOS had a higher risk in preterm birth (OR 1.69, 95% CI: 1.31\u20132.18; OR 1.24, 95% CI:1.02\u20131.50) and abortion (OR 1.38, 95% CI:1.12\u20131.71; OR 1.23, 95% CI:1.06\u20131.43).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our findings suggest that individuals with PCOS undergone ART are at a notably elevated risk for experiencing pregnancy complications and unfavorable neonatal outcomes. Nevertheless, to establish a definitive association between PCOS and pregnancy-related outcomes, it is necessary to conduct extensive prospective, blinded cohort studies and effectively control for confounding variables.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13048-023-01331-x","type":"journal-article","created":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T09:02:12Z","timestamp":1704531732000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Association between maternal polycystic ovarian syndrome undergoing assisted reproductive technology and pregnancy complications and neonatal outcomes: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"17","author":[{"given":"Miaomiao","family":"Ban","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,6]]},"reference":[{"issue":"13","key":"1331_CR1","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1056\/NEJM199509283331307","volume":"333","author":"S Franks","year":"1995","unstructured":"Franks S. Polycystic ovary syndrome. N Engl J Med. 1995;333(13):853\u201361.","journal-title":"N Engl J Med"},{"issue":"1","key":"1331_CR2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","volume":"97","author":"BCJM Fauser","year":"2012","unstructured":"Fauser BCJM, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, et al. Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril. 2012;97(1):28\u201338e25.","journal-title":"Fertil Steril"},{"issue":"9588","key":"1331_CR3","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0140-6736(07)61345-2","volume":"370","author":"RJ Norman","year":"2007","unstructured":"Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet. 2007;370(9588):685\u201397.","journal-title":"Lancet"},{"issue":"5","key":"1331_CR4","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1210\/er.2015-1018","volume":"36","author":"DA Dumesic","year":"2015","unstructured":"Dumesic DA, Oberfield SE, Stener-Victorin E, Marshall JC, Laven JS, Legro RS. Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome. Endocr Rev. 2015;36(5):487\u2013525.","journal-title":"Endocr Rev"},{"key":"1331_CR5","doi-asserted-by":"crossref","unstructured":"Azziz R, Carmina E, Chen Z, Dunaif A, Laven JSE, Legro RS et al. Polycystic ovary syndrome. Nat Reviews Disease Primers. 2016;2.","DOI":"10.1038\/nrdp.2016.57"},{"issue":"9","key":"1331_CR6","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1093\/humrep\/deab181","volume":"36","author":"S Palomba","year":"2021","unstructured":"Palomba S. Is fertility reduced in ovulatory women with polycystic ovary syndrome? An opinion paper. Hum Reprod. 2021;36(9):2421\u20138.","journal-title":"Hum Reprod"},{"issue":"3","key":"1331_CR7","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1093\/humrep\/deh109","volume":"19","author":"CJ Glueck","year":"2004","unstructured":"Glueck CJ, Goldenberg N, Wang P, Loftspring M, Sherman A. Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational Diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughout pregnancy. Hum Reprod. 2004;19(3):510\u201321.","journal-title":"Hum Reprod"},{"issue":"5","key":"1331_CR8","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1016\/j.fertnstert.2009.10.043","volume":"94","author":"S Palomba","year":"2010","unstructured":"Palomba S, Falbo A, Russo T, Tolino A, Orio F, Zullo F. Pregnancy in women with polycystic ovary syndrome: the effect of different phenotypes and features on obstetric and neonatal outcomes. Fertil Steril. 2010;94(5):1805\u201311.","journal-title":"Fertil Steril"},{"key":"1331_CR9","unstructured":"Lesser KB, Garcia FA. Association between polycystic ovary syndrome and glucose intolerance during pregnancy. (1057\u2009\u2013\u20090802 (Print))."},{"issue":"1","key":"1331_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/humupd\/dmi036","volume":"12","author":"EMEW Heijnen","year":"2006","unstructured":"Heijnen EMEW, Eijkemans MJC, Hughes EG, Laven JSE, Macklon NS, Fauser BCJM. A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome. Hum Reprod Update. 2006;12(1):13\u201321.","journal-title":"Hum Reprod Update"},{"issue":"6","key":"1331_CR11","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.ajog.2011.03.021","volume":"204","author":"LE Kjerulff","year":"2011","unstructured":"Kjerulff LE, Sanchez-Ramos L, Duffy D. Pregnancy outcomes in women with polycystic ovary syndrome: a metaanalysis. Am J Obstet Gynecol. 2011;204(6):558.e1-.e6.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"1331_CR12","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/humupd\/dmv029","volume":"21","author":"S Palomba","year":"2015","unstructured":"Palomba S, De Wilde MA, Falbo A, Koster MPH, La Sala GB, Fauser BCJM. Pregnancy Complications in women with polycystic ovary syndrome. Hum Reprod Update. 2015;21(5):575\u201392.","journal-title":"Hum Reprod Update"},{"key":"1331_CR13","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"1331_CR14","doi-asserted-by":"crossref","unstructured":"Revised. 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and Sterility. 2004;81(1):19\u201325.","DOI":"10.1016\/j.fertnstert.2003.10.004"},{"key":"1331_CR15","unstructured":"Wells GSB, O\u2019Connell D, Peterson J, Welch V, Losos M et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. 2009."},{"issue":"9","key":"1331_CR16","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1093\/humrep\/der197","volume":"26","author":"JA Barry","year":"2011","unstructured":"Barry JA, Kuczmierczyk AR, Hardiman PJ. Anxiety and depression in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2011;26(9):2442\u201351.","journal-title":"Hum Reprod"},{"issue":"11","key":"1331_CR17","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539\u201358.","journal-title":"Stat Med"},{"key":"1331_CR18","unstructured":"Egger M, Davey Smith G, Fau - Schneider M, Schneider M, Fau - Minder C, Minder C. Bias in meta-analysis detected by a simple, graphical test. (0959\u20138138 (Print))."},{"issue":"6","key":"1331_CR19","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/S0015-0282(16)55086-9","volume":"57","author":"B Urman","year":"1992","unstructured":"Urman B, Fluker MR, Yuen BH, Fleige-Zahradka BG, Zouves CG, Moon YS. The outcome of in vitro fertilization and embryo transfer in women with polycystic ovary syndrome failing to conceive after ovulation induction with exogenous gonadotropins. Fertil Steril. 1992;57(6):1269\u201373.","journal-title":"Fertil Steril"},{"issue":"5","key":"1331_CR20","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/S0015-0282(16)56287-6","volume":"60","author":"R Homburg","year":"1993","unstructured":"Homburg R, Berkowitz D, Levy T, Feldberg D, Ashkenazi J, Ben-Rafael Z. In vitro fertilization and embryo transfer for the treatment of infertility associated with polycystic ovary syndrome. Fertil Steril. 1993;60(5):858\u201363.","journal-title":"Fertil Steril"},{"issue":"8","key":"1331_CR21","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1093\/oxfordjournals.humrep.a136247","volume":"10","author":"K Hardy","year":"1995","unstructured":"Hardy K, Robinson FM, Paraschos T, Wicks R, Franks S, Winston RM. Normal development and metabolic activity of preimplantation embryos in vitro from patients with polycystic ovaries. Hum Reprod. 1995;10(8):2125\u201335.","journal-title":"Hum Reprod"},{"issue":"8","key":"1331_CR22","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1093\/oxfordjournals.humrep.a136217","volume":"10","author":"H Kodama","year":"1995","unstructured":"Kodama H, Fukuda J, Karube H, Matsui T, Shimizu Y, Tanaka T. High incidence of embryo transfer cancellations in patients with polycystic ovarian syndrome. Hum Reprod. 1995;10(8):1962\u20137.","journal-title":"Hum Reprod"},{"key":"1331_CR23","doi-asserted-by":"crossref","unstructured":"Lesser KB, Garcia FA. Association between polycystic ovary syndrome and glucose intolerance during pregnancy. 1997(1057\u2009\u2013\u20090802 (Print)).","DOI":"10.1002\/(SICI)1520-6661(199709\/10)6:5<303::AID-MFM14>3.0.CO;2-L"},{"issue":"3","key":"1331_CR24","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1093\/humrep\/12.3.474","volume":"12","author":"K Sengoku","year":"1997","unstructured":"Sengoku K, Tamate K, Takuma N, Yoshida T, Goishi K, Ishikawa M. The chromosomal normality of unfertilized oocytes from patients with polycystic ovarian syndrome. Hum Reprod. 1997;12(3):474\u20137.","journal-title":"Hum Reprod"},{"issue":"3","key":"1331_CR25","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/humrep\/14.3.601","volume":"14","author":"N Doldi","year":"1999","unstructured":"Doldi N, Marsiglio E, Destefani A, Gessi A, Merati G, Ferrari A. Elevated serum progesterone on the day of HCG administration in IVF is associated with a higher pregnancy rate in polycystic ovary syndrome. Hum Reprod. 1999;14(3):601\u20135.","journal-title":"Hum Reprod"},{"issue":"1","key":"1331_CR26","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3109\/10641959909009612","volume":"18","author":"M Fridstr\u00f6m","year":"1999","unstructured":"Fridstr\u00f6m M, Nisell H, Sj\u00f6blom P, Hillensj\u00f6 T. Are women with polycystic ovary syndrome at an increased risk of pregnancy-induced Hypertension and\/or preeclampsia? Hypertens Pregnancy. 1999;18(1):73\u201380.","journal-title":"Hypertens Pregnancy"},{"issue":"2","key":"1331_CR27","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1159\/000067719","volume":"54","author":"S Bjercke","year":"2002","unstructured":"Bjercke S, Dale PO, Tanbo T, Storeng R, Ertzeid G, Abyholm T. Impact of insulin resistance on pregnancy Complications and outcome in women with polycystic ovary syndrome. Gynecol Obstet Invest. 2002;54(2):94\u20138.","journal-title":"Gynecol Obstet Invest"},{"issue":"1","key":"1331_CR28","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/S1472-6483(10)61728-2","volume":"7","author":"AG Mulders","year":"2003","unstructured":"Mulders AG, Laven JS, Imani B, Eijkemans MJ, Fauser BC. IVF outcome in anovulatory infertility (WHO group 2)--including polycystic ovary syndrome\u2013following previous unsuccessful ovulation induction. Reprod Biomed Online. 2003;7(1):50\u20138.","journal-title":"Reprod Biomed Online"},{"issue":"4","key":"1331_CR29","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S1472-6483(10)60926-1","volume":"8","author":"B Urman","year":"2004","unstructured":"Urman B, Tiras B, Yakin K. Assisted reproduction in the treatment of polycystic ovarian syndrome. Reprod Biomed Online. 2004;8(4):419\u201330.","journal-title":"Reprod Biomed Online"},{"issue":"8","key":"1331_CR30","doi-asserted-by":"publisher","first-page":"582","DOI":"10.3109\/09513591003632043","volume":"26","author":"P Kuivasaari-Pirinen","year":"2010","unstructured":"Kuivasaari-Pirinen P, Hippelainen M, Hakkarainen H, Randell K, Heinonen S. Cumulative baby take-home rate among women with PCOS treated by IVF. Gynecol Endocrinol. 2010;26(8):582\u20139.","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"1331_CR31","doi-asserted-by":"publisher","first-page":"103","DOI":"10.5653\/cerm.2011.38.2.103","volume":"38","author":"AR Han","year":"2011","unstructured":"Han AR, Kim HO, Cha SW, Park CW, Kim JY, Yang KM, et al. Adverse pregnancy outcomes with assisted reproductive technology in non-obese women with polycystic ovary syndrome: a case-control study. Clin Exp Reprod Med. 2011;38(2):103\u20138.","journal-title":"Clin Exp Reprod Med"},{"issue":"2","key":"1331_CR32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3109\/09513590.2010.501872","volume":"27","author":"ES Nejad","year":"2011","unstructured":"Nejad ES, Saedi T, Saedi S, Rashidi BH, Nekoo ZA, Jahangiri N. Comparison of in vitro fertilisation success in patients with polycystic ovary syndrome and tubal factor. Gynecol Endocrinol. 2011;27(2):117\u201320.","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"1331_CR33","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10815-013-0151-6","volume":"31","author":"HW Li","year":"2014","unstructured":"Li HW, Lee VC, Lau EY, Yeung WS, Ho PC, Ng EH. Cumulative live-birth rate in women with polycystic ovary syndrome or isolated polycystic ovaries undergoing in-vitro fertilisation treatment. J Assist Reprod Genet. 2014;31(2):205\u201311.","journal-title":"J Assist Reprod Genet"},{"key":"1331_CR34","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.ejogrb.2014.02.041","volume":"176","author":"L Liu","year":"2014","unstructured":"Liu L, Tong X, Jiang L, Li TC, Zhou F, Zhang S. A comparison of the miscarriage rate between women with and without polycystic ovarian syndrome undergoing IVF treatment. Eur J Obstet Gynecol Reprod Biol. 2014;176:178\u201382.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"1331_CR35","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3109\/14767058.2014.921673","volume":"28","author":"HL Wan","year":"2015","unstructured":"Wan HL, Hui PW, Li HW, Ng EH. Obstetric outcomes in women with polycystic ovary syndrome and isolated polycystic ovaries undergoing in vitro fertilization: a retrospective cohort analysis. J Matern Fetal Neonatal Med. 2015;28(4):475\u20138.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"3","key":"1331_CR36","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.fertnstert.2015.11.019","volume":"105","author":"L Sterling","year":"2016","unstructured":"Sterling L, Liu J, Okun N, Sakhuja A, Sierra S, Greenblatt E. Pregnancy outcomes in women with polycystic ovary syndrome undergoing in vitro fertilization. Fertil Steril. 2016;105(3):791\u20137e2.","journal-title":"Fertil Steril"},{"issue":"3","key":"1331_CR37","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1177\/0300060517704140","volume":"45","author":"Y Chen","year":"2017","unstructured":"Chen Y, Ye B, Yang X, Zheng J, Lin J, Zhao J. Predicting the outcome of different protocols of in vitro fertilization with anti-Mu\u00fcllerian hormone levels in patients with polycystic ovary syndrome. J Int Med Res. 2017;45(3):1138\u201347.","journal-title":"J Int Med Res"},{"key":"1331_CR38","doi-asserted-by":"publisher","first-page":"575337","DOI":"10.3389\/fendo.2020.575337","volume":"11","author":"S Liu","year":"2020","unstructured":"Liu S, Mo M, Xiao S, Li L, Hu X, Hong L, et al. Pregnancy outcomes of women with polycystic ovary syndrome for the First in Vitro Fertilization treatment: a Retrospective Cohort Study with 7678 patients. Front Endocrinol (Lausanne). 2020;11:575337.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"1331_CR39","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1515\/jpm-2019-0244","volume":"49","author":"D Abdulkhalikova","year":"2021","unstructured":"Abdulkhalikova D, Koro\u0161ec S, Blickstein I, Tul N, Bokal EV, Ban Frangez H. Perinatal outcome of in vitro fertilization pregnancies in women with polycystic ovary syndrome by pregravid BMI. J Perinat Med. 2021;49(4):514\u20139.","journal-title":"J Perinat Med"},{"issue":"7","key":"1331_CR40","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1111\/1471-0528.16590","volume":"128","author":"H Cai","year":"2021","unstructured":"Cai H, Mol BW, Gordts S, Wang H, Wang T, Li N, et al. Early and late pregnancy loss in women with polycystic ovary syndrome undergoing IVF\/ICSI treatment: a retrospective cohort analysis of 21 820 pregnancies. BJOG. 2021;128(7):1160\u20139.","journal-title":"BJOG"},{"issue":"6","key":"1331_CR41","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1111\/1471-0528.16557","volume":"128","author":"S Hu","year":"2021","unstructured":"Hu S, Xu B, Long R, Jin L. The effect of polycystic ovary syndrome without hyperandrogenism on pregnancy-related outcomes: a retrospective cohort study. BJOG. 2021;128(6):1003\u201310.","journal-title":"BJOG"},{"key":"1331_CR42","doi-asserted-by":"publisher","first-page":"789395","DOI":"10.3389\/fendo.2021.789395","volume":"12","author":"L Jiang","year":"2021","unstructured":"Jiang L, Tian L, Yuan J, Xu X, Qu F, Zhang R, et al. Associations between sex hormone levels and autistic traits in infertile patients with polycystic ovary syndrome and their offspring. Front Endocrinol (Lausanne). 2021;12:789395.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"1331_CR43","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.fertnstert.2020.08.1435","volume":"115","author":"J Lin","year":"2021","unstructured":"Lin J, Guo H, Wang B, Chen Q, Zhu Q. Neonatal outcomes in women with polycystic ovary syndrome after frozen-thawed embryo transfer. Fertil Steril. 2021;115(2):447\u201354.","journal-title":"Fertil Steril"},{"issue":"1","key":"1331_CR44","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.rbmo.2020.09.019","volume":"42","author":"R Valdimarsdottir","year":"2021","unstructured":"Valdimarsdottir R, Wikstr\u00f6m AK, Kallak TK, Elenis E, Axelsson O, Preissl H, et al. Pregnancy outcome in women with polycystic ovary syndrome in relation to second-trimester testosterone levels. Reprod Biomed Online. 2021;42(1):217\u201325.","journal-title":"Reprod Biomed Online"},{"issue":"5","key":"1331_CR45","doi-asserted-by":"publisher","first-page":"553","DOI":"10.4328\/ACAM.20628","volume":"12","author":"A Yurci","year":"2021","unstructured":"Yurci A, Gungor ND, Gurbuz T. Does polycystic ovarian syndrome increase the risk of congenital anomalies in intracytoplasmic sperm injection cycles? Annals of Clinical and Analytical Medicine. 2021;12(5):553\u20137.","journal-title":"Annals of Clinical and Analytical Medicine"},{"issue":"1","key":"1331_CR46","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1186\/s12884-022-05011-4","volume":"22","author":"HY Jie","year":"2022","unstructured":"Jie HY, Zhou X, Zhao MP, Hu M, Mai QY, Zhou CQ. Pregnancy outcomes in patients with polycystic ovary syndrome who conceived after single thawed blastocyst transfer: a propensity score-matched study. BMC Pregnancy Childbirth. 2022;22(1):718.","journal-title":"BMC Pregnancy Childbirth"},{"key":"1331_CR47","doi-asserted-by":"publisher","first-page":"878853","DOI":"10.3389\/fendo.2022.878853","volume":"13","author":"Z Ni","year":"2022","unstructured":"Ni Z, Mei S, You S, Lin Y, Cheng W, Zhou L, et al. Adverse effects of polycystic ovarian syndrome on pregnancy outcomes in women with frozen-thawed embryo transfer: Propensity score-matched study. Front Endocrinol (Lausanne). 2022;13:878853.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"1331_CR48","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.rbmo.2022.05.024","volume":"45","author":"M Qiu","year":"2022","unstructured":"Qiu M, Qu J, Tian Y, Wang Y. The influence of polycystic ovarian syndrome on obstetric and neonatal outcomes after frozen-thawed embryo transfer. Reprod Biomed Online. 2022;45(4):745\u201353.","journal-title":"Reprod Biomed Online"},{"key":"1331_CR49","first-page":"1405","volume":"13","author":"MJ Shinde","year":"2022","unstructured":"Shinde MJ, Wagh AR, Samantara N, Chilakalapalli RH, Harshitha P, Priya S, et al. In Vitro Fertilisation (IVF) pregnancy: a comparative study with endocrine dysfunction patients having PCOS. J Pharm Negat Results. 2022;13:1405\u201311.","journal-title":"J Pharm Negat Results"},{"key":"1331_CR50","doi-asserted-by":"crossref","unstructured":"Wang Q, Wang H, Li P, Li X, Wang Z, Yan L et al. Association of Polycystic Ovary Syndrome Phenotypes with adverse pregnancy outcomes after In-Vitro Fertilization\/Intracytoplasmic sperm injection. Front Endocrinol. 2022;13.","DOI":"10.3389\/fendo.2022.889029"},{"issue":"1","key":"1331_CR51","doi-asserted-by":"publisher","first-page":"14852","DOI":"10.1038\/s41598-022-18704-9","volume":"12","author":"Q Wang","year":"2022","unstructured":"Wang Q, Zheng Y, Li P, Zhang G, Gao S, Wang Z, et al. Increased risk of abortion after frozen-thawed embryo transfer in women with polycystic ovary syndrome phenotypes a and D. Sci Rep. 2022;12(1):14852.","journal-title":"Sci Rep"},{"issue":"51","key":"1331_CR52","first-page":"e4863","volume":"95","author":"HF Yu","year":"2016","unstructured":"Yu HF, Chen HS, Rao DP, Gong J. Association between polycystic ovary syndrome and the risk of pregnancy Complications a PRISMA-compliant systematic review and meta-analysis. Med (United States). 2016;95(51):e4863.","journal-title":"Med (United States)"},{"key":"1331_CR53","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1186\/1477-7827-11-56","volume":"11","author":"JZ Qin","year":"2013","unstructured":"Qin JZ, Pang LH, Li MJ, Fan XJ, Huang RD, Chen HY. Obstetric Complications in women with polycystic ovary syndrome: a systematic review and meta-analysis. Reprod Biol Endocrinol. 2013;11:1477\u20137827. (Electronic)):56.","journal-title":"Reprod Biol Endocrinol"},{"issue":"2","key":"1331_CR54","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.rbmo.2019.03.203","volume":"39","author":"T Sha","year":"2019","unstructured":"Sha T, Wang X, Cheng W, Yan Y. A meta-analysis of pregnancy-related outcomes and Complications in women with polycystic ovary syndrome undergoing IVF. Reprod Biomed Online. 2019;39(2):281\u201393.","journal-title":"Reprod Biomed Online"},{"issue":"3","key":"1331_CR55","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.tem.2016.11.008","volume":"28","author":"S Palomba","year":"2017","unstructured":"Palomba S, Daolio J, La Sala GB. Oocyte competence in women with polycystic ovary syndrome. Trends Endocrinol Metab. 2017;28(3):186\u201398.","journal-title":"Trends Endocrinol Metab"},{"key":"1331_CR56","doi-asserted-by":"publisher","first-page":"647522","DOI":"10.3389\/fcell.2021.647522","volume":"9","author":"G Yang","year":"2021","unstructured":"Yang G, Yao G, Xu Z, Fan H, Liu X, He J, et al. Expression level of ADAMTS1 in Granulosa cells of PCOS patients is related to Granulosa cell function, Oocyte Quality, and embryo development. Front Cell Dev Biol. 2021;9:647522.","journal-title":"Front Cell Dev Biol"},{"issue":"8724","key":"1331_CR57","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/0140-6736(90)92765-A","volume":"336","author":"L Regan","year":"1990","unstructured":"Regan L, Owen EJ, Jacobs HS. Hypersecretion of luteinising hormone, infertility, and miscarriage. Lancet. 1990;336(8724):1141\u20134.","journal-title":"Lancet"},{"issue":"2","key":"1331_CR58","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.fertnstert.2015.04.044","volume":"104","author":"BJ Stegmann","year":"2015","unstructured":"Stegmann BJ, Santillan M, Leader B, Smith E, Santillan D. Changes in antim\u00fcllerian hormone levels in early pregnancy are associated with preterm birth. Fertil Steril. 2015;104(2):347\u201355e3.","journal-title":"Fertil Steril"},{"issue":"6","key":"1331_CR59","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/s41591-018-0035-5","volume":"24","author":"B Tata","year":"2018","unstructured":"Tata B, Mimouni NEH, Barbotin AL, Malone SA, Loyens A, Pigny P, et al. Elevated prenatal anti-M\u00fcllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood. Nat Med. 2018;24(6):834\u201346.","journal-title":"Nat Med"},{"issue":"2","key":"1331_CR60","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.fertnstert.2019.10.036","volume":"113","author":"SG Vitale","year":"2020","unstructured":"Vitale SG, Riemma G, Cianci A. Antim\u00fcllerian hormone in polycystic ovarian syndrome: from a key role in the pathogenesis to a sentinel for pre-term birth prediction. Fertil Steril. 2020;113(2):335\u20136.","journal-title":"Fertil Steril"},{"issue":"9398","key":"1331_CR61","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/S0140-6736(03)14942-2","volume":"362","author":"EA Ryan","year":"2003","unstructured":"Ryan EA. Hormones and insulin resistance during pregnancy. Lancet. 2003;362(9398):1777\u20138.","journal-title":"Lancet"},{"key":"1331_CR62","doi-asserted-by":"crossref","unstructured":"Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010;8(1).","DOI":"10.1186\/1741-7015-8-41"},{"issue":"12","key":"1331_CR63","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1093\/humrep\/deq272","volume":"25","author":"SM Veltman-Verhulst","year":"2010","unstructured":"Veltman-Verhulst SM, Van Haeften TW, Eijkemans MJC, De Valk HW, Fauser BCJM, Goverde AJ. Sex hormone-binding globulin concentrations before conception as a predictor for gestational Diabetes in women with polycystic ovary syndrome. Hum Reprod. 2010;25(12):3123\u20138.","journal-title":"Hum Reprod"},{"key":"1331_CR64","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1186\/1477-7827-12-3","volume":"12","author":"S Palomba","year":"2014","unstructured":"Palomba S, Falbo A, La Sala GB. Metformin and gonadotropins for ovulation induction in patients with polycystic ovary syndrome: a systematic review with meta-analysis of randomized controlled trials. Reprod Biol Endocrinol. 2014;12:1477\u20137827. (Electronic)):3.","journal-title":"Reprod Biol Endocrinol"},{"issue":"20","key":"1331_CR65","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1056\/NEJM199611143352002","volume":"335","author":"HP Schobel","year":"1996","unstructured":"Schobel HP, Fischer T, Heuszer K, Geiger H, Schmieder RE. Preeclampsia -- a state of sympathetic overactivity. N Engl J Med. 1996;335(20):1480\u20135.","journal-title":"N Engl J Med"},{"issue":"8","key":"1331_CR66","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1093\/humrep\/dei009","volume":"20","author":"T Sir-Petermann","year":"2005","unstructured":"Sir-Petermann T, Hitchsfeld C, Maliqueo M, Codner E, Echibur\u00fa B, Gazit\u00faa R, et al. Birth weight in offspring of mothers with polycystic ovarian syndrome. Hum Reprod. 2005;20(8):2122\u20136.","journal-title":"Hum Reprod"},{"key":"1331_CR67","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1757-2215-3-23","volume":"3","author":"A Falbo","year":"2010","unstructured":"Falbo A, Rocca M, Russo T, D\u2019Ettore A, Tolino A, Zullo F, et al. Changes in androgens and insulin sensitivity indexes throughout pregnancy in women with polycystic ovary syndrome (PCOS): relationships with adverse outcomes. J Ovarian Res. 2010;3:23.","journal-title":"J Ovarian Res"},{"issue":"1","key":"1331_CR68","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1093\/humupd\/dmv044","volume":"22","author":"S Vannuccini","year":"2016","unstructured":"Vannuccini S, Clifton VL, Fraser IS, Taylor HS, Critchley H, Giudice LC, et al. Infertility and reproductive disorders: impact of hormonal and inflammatory mechanisms on pregnancy outcome. Hum Reprod Update. 2016;22(1):104\u201315.","journal-title":"Hum Reprod Update"},{"issue":"1","key":"1331_CR69","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.mce.2010.08.002","volume":"335","author":"A Repaci","year":"2011","unstructured":"Repaci A, Gambineri A, Pasquali R. The role of low-grade inflammation in the polycystic ovary syndrome. Mol Cell Endocrinol. 2011;335(1):30\u201341.","journal-title":"Mol Cell Endocrinol"},{"issue":"10","key":"1331_CR70","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1365-2362.2006.01712.x","volume":"36","author":"E Diamanti-Kandarakis","year":"2006","unstructured":"Diamanti-Kandarakis E, Alexandraki K, Piperi C, Protogerou A, Katsikis I, Paterakis T, et al. Inflammatory and endothelial markers in women with polycystic ovary syndrome. Eur J Clin Invest. 2006;36(10):691\u20137.","journal-title":"Eur J Clin Invest"},{"issue":"6","key":"1331_CR71","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1016\/j.fertnstert.2009.06.009","volume":"92","author":"MJ Chen","year":"2009","unstructured":"Chen MJ, Chen HF, Chen SU, Ho HN, Yang YS, Yang WS. The relationship between follistatin and chronic low-grade inflammation in women with polycystic ovary syndrome. Fertil Steril. 2009;92(6):2041\u20134.","journal-title":"Fertil Steril"},{"issue":"6","key":"1331_CR72","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.ajog.2013.08.030","volume":"209","author":"N Hofer","year":"2013","unstructured":"Hofer N, Kothari R, Morris N, Muller W, Resch B. The fetal inflammatory response syndrome is a risk factor for morbidity in preterm neonates. Am J Obstet Gynecol. 2013;209(6):542. e1- e11.","journal-title":"Am J Obstet Gynecol"},{"issue":"4 Pt 1","key":"1331_CR73","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/0002-9378(91)90422-N","volume":"165","author":"R Romero","year":"1991","unstructured":"Romero R, Ceska M, Avila C, Mazor M, Behnke E, Lindley I. Neutrophil attractant\/activating peptide-1\/interleukin-8 in term and preterm parturition. Am J Obstet Gynecol. 1991;165(4 Pt 1):813\u201320.","journal-title":"Am J Obstet Gynecol"},{"key":"1331_CR74","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/jcm11216521","volume":"11","author":"N Jovic","year":"2022","unstructured":"Jovic N, Milovanovic M, Jovic JJ, Ilic MB, Rakic D, Milenkovic V, et al. The expression of IL-1beta correlates with the expression of Galectin-3 in the tissue at the maternal-fetal interface during the term and Preterm Labor. J Clin Med. 2022;11:21.","journal-title":"J Clin Med"},{"issue":"3","key":"1331_CR75","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/humupd\/dmaa051","volume":"27","author":"S Palomba","year":"2018","unstructured":"Palomba S, Piltonen TT, Giudice LC. Endometrial function in women with polycystic ovary syndrome: a comprehensive review. Hum Reprod Update. 2018;27(3):584\u2013618.","journal-title":"Hum Reprod Update"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-023-01331-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-023-01331-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-023-01331-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T21:16:18Z","timestamp":1704575778000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-023-01331-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,6]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1331"],"URL":"https:\/\/doi.org\/10.1186\/s13048-023-01331-x","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,6]]},"assertion":[{"value":"27 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}